Search

Brian R Stanton

Examiner (ID: 9396)

Most Active Art Unit
1804
Art Unit(s)
1632, 1621, 1804, 1819, 1600
Total Applications
312
Issued Applications
94
Pending Applications
102
Abandoned Applications
115

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18980100 [patent_doc_number] => 11905260 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-02-20 [patent_title] => N'-(1-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/486813 [patent_app_country] => US [patent_app_date] => 2023-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4006 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18486813 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/486813
N'-(1-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound Oct 12, 2023 Issued
Array ( [id] => 18980102 [patent_doc_number] => 11905262 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-02-20 [patent_title] => N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/379024 [patent_app_country] => US [patent_app_date] => 2023-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4021 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379024 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/379024
N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as an antimicrobial compound Oct 10, 2023 Issued
Array ( [id] => 18806990 [patent_doc_number] => 20230381323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => RELEASABLE CONJUGATES [patent_app_type] => utility [patent_app_number] => 18/234142 [patent_app_country] => US [patent_app_date] => 2023-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18234142 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/234142
RELEASABLE CONJUGATES Aug 14, 2023 Pending
Array ( [id] => 18753821 [patent_doc_number] => 20230357119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF CARBAPROSTACYCLIN ANALOGUES [patent_app_type] => utility [patent_app_number] => 18/325214 [patent_app_country] => US [patent_app_date] => 2023-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16703 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18325214 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/325214
PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF CARBAPROSTACYCLIN ANALOGUES May 29, 2023 Pending
Array ( [id] => 18869767 [patent_doc_number] => 11857547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Compositions and methods for opioid antagonist delivery [patent_app_type] => utility [patent_app_number] => 18/195142 [patent_app_country] => US [patent_app_date] => 2023-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12096 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18195142 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/195142
Compositions and methods for opioid antagonist delivery May 8, 2023 Issued
Array ( [id] => 18753868 [patent_doc_number] => 20230357176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => PROCESS-SCALE SYNTHESIS OF UROLITHIN A [patent_app_type] => utility [patent_app_number] => 18/138357 [patent_app_country] => US [patent_app_date] => 2023-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138357 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/138357
PROCESS-SCALE SYNTHESIS OF UROLITHIN A Apr 23, 2023 Pending
Array ( [id] => 18597183 [patent_doc_number] => 20230271976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => OPIOID RECEPTOR MODULATORS [patent_app_type] => utility [patent_app_number] => 18/297081 [patent_app_country] => US [patent_app_date] => 2023-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47420 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297081 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/297081
OPIOID RECEPTOR MODULATORS Apr 6, 2023 Pending
Array ( [id] => 18496007 [patent_doc_number] => 20230218534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => SYSTEMS AND METHODS FOR INCREASING STABILITY OF DRONABINOL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/090722 [patent_app_country] => US [patent_app_date] => 2022-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18090722 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/090722
SYSTEMS AND METHODS FOR INCREASING STABILITY OF DRONABINOL COMPOSITIONS Dec 28, 2022 Pending
Array ( [id] => 18364538 [patent_doc_number] => 20230146129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS [patent_app_type] => utility [patent_app_number] => 18/089065 [patent_app_country] => US [patent_app_date] => 2022-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18089065 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/089065
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS Dec 26, 2022 Pending
Array ( [id] => 18281354 [patent_doc_number] => 20230096826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => EFFICIENT NEW PROCESS FOR SYNTHESIS OF 2-AMINO-5-CHLORO-N-,3-DIMETHYLBENZAMIDE [patent_app_type] => utility [patent_app_number] => 18/070827 [patent_app_country] => US [patent_app_date] => 2022-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11970 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070827 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/070827
EFFICIENT NEW PROCESS FOR SYNTHESIS OF 2-AMINO-5-CHLORO-N-,3-DIMETHYLBENZAMIDE Nov 28, 2022 Pending
Array ( [id] => 18948121 [patent_doc_number] => 11891402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-06 [patent_title] => Compositions and methods for treating cancer [patent_app_type] => utility [patent_app_number] => 18/058655 [patent_app_country] => US [patent_app_date] => 2022-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 58 [patent_no_of_words] => 60983 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058655 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/058655
Compositions and methods for treating cancer Nov 22, 2022 Issued
Array ( [id] => 18725750 [patent_doc_number] => 20230339954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => Heterocyclic Compounds as RET Kinase Inhibitors [patent_app_type] => utility [patent_app_number] => 17/992049 [patent_app_country] => US [patent_app_date] => 2022-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992049 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/992049
Heterocyclic Compounds as RET Kinase Inhibitors Nov 21, 2022 Pending
Array ( [id] => 18285537 [patent_doc_number] => 20230101009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA [patent_app_type] => utility [patent_app_number] => 17/991558 [patent_app_country] => US [patent_app_date] => 2022-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10474 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17991558 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/991558
THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA Nov 20, 2022 Pending
Array ( [id] => 18285220 [patent_doc_number] => 20230100692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => SYNTHETIC PROCESS AND NOVEL INTERMEDIATES [patent_app_type] => utility [patent_app_number] => 17/990939 [patent_app_country] => US [patent_app_date] => 2022-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17990939 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/990939
SYNTHETIC PROCESS AND NOVEL INTERMEDIATES Nov 20, 2022 Pending
Array ( [id] => 18915756 [patent_doc_number] => 11878022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-23 [patent_title] => Hydrochlorothiazide compositions [patent_app_type] => utility [patent_app_number] => 18/053197 [patent_app_country] => US [patent_app_date] => 2022-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12312 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053197 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053197
Hydrochlorothiazide compositions Nov 6, 2022 Issued
Array ( [id] => 18351576 [patent_doc_number] => 20230139687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => Preparation Methods and Uses of Purified Fulvic Acid [patent_app_type] => utility [patent_app_number] => 18/050743 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1202 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050743 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/050743
Preparation Methods and Uses of Purified Fulvic Acid Oct 27, 2022 Pending
Array ( [id] => 18350135 [patent_doc_number] => 20230138246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => USE OF DIHYDROBERBERINE OR ITS DERIVATIVES FOR ANTI-AGING [patent_app_type] => utility [patent_app_number] => 17/975028 [patent_app_country] => US [patent_app_date] => 2022-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5249 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975028 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/975028
USE OF DIHYDROBERBERINE OR ITS DERIVATIVES FOR ANTI-AGING Oct 26, 2022 Pending
Array ( [id] => 18211345 [patent_doc_number] => 20230057608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => METHODS FOR THE SYNTHESIS OF ACTIVATED ETHYLFUMARATES AND THEIR USE AS INTERMEDIATES [patent_app_type] => utility [patent_app_number] => 17/972220 [patent_app_country] => US [patent_app_date] => 2022-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11420 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972220 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/972220
METHODS FOR THE SYNTHESIS OF ACTIVATED ETHYLFUMARATES AND THEIR USE AS INTERMEDIATES Oct 23, 2022 Pending
Array ( [id] => 18322752 [patent_doc_number] => 20230120880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => COMPOSITIONS COMPRISING CIPROFLOXACIN AND CELECOXIB [patent_app_type] => utility [patent_app_number] => 18/047289 [patent_app_country] => US [patent_app_date] => 2022-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8391 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047289 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047289
COMPOSITIONS COMPRISING CIPROFLOXACIN AND CELECOXIB Oct 17, 2022 Pending
Array ( [id] => 18953571 [patent_doc_number] => 20240041898 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2024-02-08 [patent_title] => NEUROSTEROIDS AND ENANTIOMERS THEREOF FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/046244 [patent_app_country] => US [patent_app_date] => 2022-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11179 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046244 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/046244
NEUROSTEROIDS AND ENANTIOMERS THEREOF FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS Oct 12, 2022 Pending
Menu